Native collagen matrix plus PHMB antimicrobial in hard-to-heal diabetic foot ulcers: results from the PREPARE randomised controlled trial
Journal of Wound Care · 2026
DOI: 10.12968/jowc.2026.0369 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Wound Care, 2026. Verfasst von Leandro Tapia Garcia und 9 weiteren Autor:innen. Beteiligte Einrichtung: SerenaGroup, Inc, Norwell, MA, US. Hauptthemen laut MEDLINE: Diabetic Foot, Biguanides, Wound Healing, Collagen Type I. Die Arbeit nennt 27 Literaturangaben.
Themen: Diabetisches Fußsyndrom
Abstract (Originalsprache)
Objective
PREPARE was a prospective, multicentre, randomised controlled trial evaluating purified native type 1 collagen extracellular matrix plus polyhexamethylene biguanide (PCMP) with standard of care (SoC) versus SoC alone in patients with hard-to-heal diabetic foot ulcers (DFUs).
Method
Across 25 US sites, patients with type 1 or type 2 diabetes and hard-to-heal DFUs measuring 1–25cm 2 were enrolled. Patients demonstrating ≥40 percent area reduction (PAR) during four weeks of screening were excluded to restrict the study population to those with hard-to-heal wounds. SoC included sharp debridement, saline cleansing, use of moisture-balancing dressings and offloading. The primary endpoint was complete wound closure within 12 weeks, confirmed two weeks later. Secondary endpoints included time to closure, PAR and adverse events (AEs).
Results
A total of 170 patients were randomised (PCMP+SoC, n=96; SoC alone, n=74). Complete wound closure occurred in 42% of patients receiving PCMP+SoC versus 27% of patients receiving SoC alone (absolute difference 14.6%; 95% confidence interval: 0.15%, 27.9%; p=0.047). Mean PAR was greater with PCMP+SoC than with SoC alone (75.23% versus 58.06%, respectively). No AEs or serious AEs were attributed to PCMP.
Conclusion
In this study, use of PCMP+SoC significantly improved 12-week closure outcomes in patients with hard-to-heal DFUs compared with SoC alone, supporting its use as an adjunctive antimicrobial barrier for these types of wounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- SerenaGroup, Inc, Norwell, MA, US.
- Advanced Foot Care, Phoenix, AZ, US.
- Advanced Podiatry Research Group, South Miami, FL, US.
- Limb Preservation Platform, Inc., Fresno, CA, US.
- Futuro Clinical Trials, McAllen, TX, US.
- Kent State University College of Podiatric Medicine, Independence, OH, US.
Zitieren
APA
Garcia, L. T., Banks, J., Rodriguez, M., Cazzell, S. M., Caporusso, J. M., Cole, W., Shi, D., Cook, E., Tramelli, B., & Serena, T. E. (2026). Native collagen matrix plus PHMB antimicrobial in hard-to-heal diabetic foot ulcers: results from the PREPARE randomised controlled trial. Journal of Wound Care. https://doi.org/10.12968/jowc.2026.0369
Vancouver
Garcia LT, Banks J, Rodriguez M, Cazzell SM, Caporusso JM, Cole W, et al. Native collagen matrix plus PHMB antimicrobial in hard-to-heal diabetic foot ulcers: results from the PREPARE randomised controlled trial. Journal of Wound Care. 2026. doi:10.12968/jowc.2026.0369
BibTeX
@article{Garcia2026,
author = {Garcia, Leandro Tapia and Banks, Jaminelli and Rodriguez, Manuel and Cazzell, Shawn M and Caporusso, Joseph M and Cole, Windy and Shi, Dereck and Cook, Emily and Tramelli, Brianna and Serena, Thomas E},
title = {Native collagen matrix plus PHMB antimicrobial in hard-to-heal diabetic foot ulcers: results from the PREPARE randomised controlled trial},
journal = {Journal of Wound Care},
year = {2026},
doi = {10.12968/jowc.2026.0369}
}
EUVIMED